Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (12) , 1871-1875
- https://doi.org/10.1016/s0959-8049(98)00259-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mature results from three large controlled studies with raltitrexed ('Tomudex')British Journal of Cancer, 1998
- Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trialCancer, 1995
- Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung CancerNew England Journal of Medicine, 1993
- Influence of sex and age on fluorouracil clearance.Journal of Clinical Oncology, 1992
- Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.Journal of Clinical Oncology, 1991
- Effect of age on hematopoiesis in manBlood, 1984
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology groupCancer, 1983
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976